Brief: Blackrock's Long Position In Wuxi Biologics (Cayman) Increases To 6.14% On Jan 2, HKEX Shows
Jan 7 (Reuters) - HKEX: BLACKROCK'S LONG POSITION IN WUXI BIOLOGICS (CAYMAN) 2269.HK INCREASES TO 6.14% ON JAN 2 FROM 5.32% Further company coverage: 2269.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln